Stryker (SYK) EBITDA (2009 - 2026)

Stryker (SYK) has reported EBITDA for 18 consecutive years, with $1.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 49.06% year-over-year to $1.7 billion in Q2 2026; TTM through Jun 2026 was $5.5 billion, a 53.04% increase from a year earlier, with the FY2025 full-year figure at $4.9 billion, up 32.53% from the prior year.
• EBITDA was $1.7 billion for Q2 2026 at Stryker, up from $936.0 million in the prior quarter.
• Over five years, EBITDA peaked at $1.8 billion in Q4 2025 and troughed at $447.0 million in Q1 2022.
• A 5-year average of $994.6 million and a median of $950.5 million in 2023 frame the typical range for EBITDA.
• Across the five-year window, EBITDA plunged 53.78% in 2024 and soared 210.5% in 2025, its largest moves.
• Over 5 years, EBITDA stood at $814.0 million in 2022, then jumped by 54.42% to $1.3 billion in 2023, then plunged by 53.78% to $581.0 million in 2024, then soared by 210.5% to $1.8 billion in 2025, then decreased by 8.04% to $1.7 billion in 2026.
• The last three EBITDA figures came in at $1.7 billion (Q2 2026), $936.0 million (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.